1-2 of 2
Dolores Caballero Barrigon, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Anas Younes, MD, Joshua Brody, MD, Cecilia Carpio, MD, Armando Lopez-Guillermo, Dina Ben-Yehuda, MD, A. Burhan Ferhanoglu, MD, Arnon Nagler, MD, Muhit Ozcan, MD, Irit Avivi, MD, Francesc Bosch Albareda, MD PhD, María Dolores Caballero Barrigón, MD PhD, Aisha Masood, MD, Michael Streit, MD MBA, John Alvarez, MD PhD, Rob Ceulemans, MS, Behzad Kharabi Masouleh, MD, Sriram Balasubramanian, PhD, Michael Schaffer, PhD, Shean-Sheng Wang, PhD, Nele Fourneau, MD, Wojciech Jurczak, PhDMD
Journal: Blood
Blood (2017) 130 (Supplement 1): 833.
https://doi.org/10.1182/blood.V130.Suppl_1.833.833
Published: 2017
Journal Articles

An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)

Anas Younes, MD, Gilles Salles, Giovanni Martinelli, R. Gregory Bociek, MD, Dolores Caballero Barrigon, MD, Eva Gonzalez Barca, Mehmet Turgut, MD PhD, John F. Gerecitano, MD, Fabian Herbst, Lisa Williams, Nabanita Mukherjee, Ranjana Tavorath, Won Seog Kim, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1493.
https://doi.org/10.1182/blood.V126.23.1493.1493
Published: 2015